<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00582322</url>
  </required_header>
  <id_info>
    <org_study_id>92-007</org_study_id>
    <nct_id>NCT00582322</nct_id>
  </id_info>
  <brief_title>Genetic Studies in Breast Cancer</brief_title>
  <official_title>Genetic Studies in Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the specific genetic alterations associated with&#xD;
      breast cancer. This will leat to a better understanding of the genetic causes of breast&#xD;
      cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is estimated that 175,000 new breast cancer cases and 44,5000 cancer deaths will result&#xD;
      from female breast cancer in 1991. One of the most important risk factors is a family history&#xD;
      of breast cancer. A susceptibility allele which accounts for a large proportion of familial&#xD;
      breast cancer has been localized to chromosome 17q and attempts to clone the susceptibility&#xD;
      are proceeding rapidly. The existence of recognized susceptibility loci and the awareness of&#xD;
      a significan proportion of genetic predisposition and the associated penetrances remain&#xD;
      unknown and are impossible to estimate without bias from previous studies. This study is&#xD;
      designed to estimate heterogeniety and prenetrance in a series of unslected families,&#xD;
      identify additional breast cancer susceptibility locs, as well as provide resources for gene&#xD;
      isolation and mutation analysis studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1992</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">483</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Ovarian Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with breast cancer seen at MSKCC and healthy family members.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient with breast cancer under age 41&#xD;
&#xD;
          -  patient with bilateral breast cancer 41-50 years old or 41-50 years old with a first&#xD;
             degree relative (mother, sister, daughter) with breast cancer diagnosed under age 50&#xD;
&#xD;
          -  patient with ovarian cancer with first degree relative with either ovarian cancer&#xD;
             diagnosed at any age or breast cancer diagnosed under age 60&#xD;
&#xD;
          -  patient any age with either ovarian or breast cancer who have 2 first degree rleatives&#xD;
             with either ovarian cancer diagnosed at any age or breast cancer diagnosed under age&#xD;
             50&#xD;
&#xD;
          -  relatives of any of the above patients will be included in this trial if a genetic&#xD;
             abnormality is found in the patient's blood sample&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        N/A&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teresa Gilewski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org</url>
    <description>Memorial Sloan-Kettering Cancer Center</description>
  </link>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2007</study_first_posted>
  <last_update_submitted>July 17, 2009</last_update_submitted>
  <last_update_submitted_qc>July 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>Teresa Gilewski, MD</name_title>
    <organization>Memorial Sloan-Kettering Cancer Center</organization>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Ovarian Cancer</keyword>
  <keyword>Family History</keyword>
  <keyword>Genetic Studies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

